Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016

In September 2015, 4CMenB meningococcal vaccine was introduced into the United Kingdom infant immunization program without phase 3 trial information. Understanding the effect of this program requires enhanced surveillance of invasive meningococcal disease (IMD) Neisseria meningitidis isolates and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Charlene M.C., Lucidarme, Jay, Borrow, Ray, Smith, Andrew, Cameron, J. Claire, Moxon, E. Richard, Maiden, Martin C.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875271/
https://www.ncbi.nlm.nih.gov/pubmed/29553330
http://dx.doi.org/10.3201/eid2404.171480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875271/
https://www.ncbi.nlm.nih.gov/pubmed/29553330
http://dx.doi.org/10.3201/eid2404.171480

Ejemplares similares